BIO-RAD LABORATORIES, INC.
Updates & Highlights
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Tight Market with Strategic Growth Potential
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Tight Market with Strategic Growth Potential
DirectorsTalk Interviews · 5 days ago
Why Bio-Rad Laboratories, Inc. (NYSE:BIO) Could Be Worth Watching
Why Bio-Rad Laboratories, Inc. (NYSE:BIO) Could Be Worth Watching
富途牛牛 · 6 days ago
[144] BIO-RAD LABORATORIES, INC. SEC Filing
[144] BIO-RAD LABORATORIES, INC. SEC Filing
Stock Titan · 9 days ago
Recent Openings
View all 1 jobsCulture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
Parental Leave
Family-friendly policies
401(k) Match
Retirement savings
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Bio-Rad Laboratories, Inc.?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company →News & Press
15 recentBio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Tight Market with Strategic Growth Potential
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Tight Market with Strategic Growth Potential
DirectorsTalk Interviews · 5 days ago
Why Bio-Rad Laboratories, Inc. (NYSE:BIO) Could Be Worth Watching
Why Bio-Rad Laboratories, Inc. (NYSE:BIO) Could Be Worth Watching
富途牛牛 · 6 days ago
[144] BIO-RAD LABORATORIES, INC. SEC Filing
[144] BIO-RAD LABORATORIES, INC. SEC Filing
Stock Titan · 9 days ago
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating the Medical Device Terrain with a 3.22% Upside
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating the Medical Device Terrain with a 3.22% Upside
DirectorsTalk Interviews · 12 days ago
Bio-Rad Laboratories, Inc. Class B Trade Ideas — BOATS:BIO.B
Bio-Rad Laboratories, Inc. Class B Trade Ideas — BOATS:BIO.B
TradingView · 14 days ago
Bio-Rad Laboratories, Inc. Class B Trade Ideas — LS:862449
Bio-Rad Laboratories, Inc. Class B Trade Ideas — LS:862449
TradingView · 21 days ago
Number of shareholders of Bio-Rad Laboratories, Inc. – NYSE:BIO
Number of shareholders of Bio-Rad Laboratories, Inc. – NYSE:BIO
TradingView · 21 days ago
Number of shareholders of Bio-Rad Laboratories, Inc. Class B – LS:862449
Number of shareholders of Bio-Rad Laboratories, Inc. Class B – LS:862449
TradingView · 21 days ago
Bio-Rad Laboratories, Inc. Class A Common Stock (NY: BIO
Bio-Rad Laboratories, Inc. Class A Common Stock (NY: BIO
FinancialContent · about 1 month ago
Bio-Rad Laboratories, Inc. Q1 2026 earnings preview
Bio-Rad Laboratories, Inc. Q1 2026 earnings preview
MSN · about 1 month ago
Bio-Rad Laboratories, Inc. (BIO) Investor Outlook: Navigating The 11.58% Potential Upside
Bio-Rad Laboratories, Inc. (BIO) Investor Outlook: Navigating The 11.58% Potential Upside
DirectorsTalk Interviews · about 1 month ago
Bio-Rad Laboratories, Inc. Q1 2026 Earnings Call Summary
Bio-Rad Laboratories, Inc. Q1 2026 Earnings Call Summary
Yahoo Finance · about 1 month ago
Bio-Rad Laboratories, Inc. (BIO) PT Reduced to $300 by Citigroup Amid Process Chromatography Concerns
Bio-Rad Laboratories, Inc. (BIO) PT Reduced to $300 by Citigroup Amid Process Chromatography Concerns
Yahoo Finance · about 1 month ago
Bio-Rad Laboratories, Inc. (BIO) Achieves Modest Revenue Growth and Robust Free Cash Flow Growth
Bio-Rad Laboratories, Inc. (BIO) Achieves Modest Revenue Growth and Robust Free Cash Flow Growth
Yahoo Finance · 4 months ago
Bio-Rad Laboratories, Inc. Q4 2025 Earnings Call Summary
Bio-Rad Laboratories, Inc. Q4 2025 Earnings Call Summary
Yahoo Finance · 4 months ago